Senti Bio Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202
Senti Bio delivers exciting initial Phase 1 data for SENTI-202, with 2 of 3 Acute…
Continue ReadingSenti Bio delivers exciting initial Phase 1 data for SENTI-202, with 2 of 3 Acute…
Continue ReadingAs a sponsor of NSG Bio, Amgen is privileged to award one promising start-up company…
Continue ReadingNSG BioLabs and Eppendorf Group partner to support biotech companies in Singapore
Continue ReadingFresh funding will be used to augment NSG BioLabs' infrastructure, services, and benefits for residents,…
Continue ReadingThe funds will go towards new facilities and co-working sites, likely around the Biopolis and…
Continue ReadingVerImmune wants to offer new treatment possibilities for patients facing limited options or resistance to…
Continue ReadingDespite its short history, Albatroz has been awarded a number of accolades, including the inaugural…
Continue ReadingTo ensure the safety of researchers and the surrounding environment, laboratories are categorized into different…
Continue ReadingThe traditional 9-to-5 office setup is evolving, with co-working spaces emerging as a popular alternative…
Continue ReadingSingapore's strategic commitment to building a robust biotech ecosystem is fundamentally anchored in its dedication…
Continue Reading